Back to results
US 2020/0377441 A1Published application
Methods of protecting an organ using tetrahydrocurcumin and phosphatidylcholine
OwnerBhupinder SINGHinventor
Life of this patent
Estimating the term…
Abstract
Pharmaceutical formulations of tetrahydrocurcumin and liposomes are described herein. The liposomes may comprise at least a first lipid, wherein the first lipid is a phospholipid or polyenylphosphatidylocholine are also disclosed.
Claims20
A method of treating, inhibiting, or ameliorating a disorder in a subject comprising:
- administering a pharmaceutical formulation to the subject, the pharmaceutical formulation comprising a non-deuterated form of tetrahydrocurcumin or a deuterated form of tetrahydrocurcumin and a pharmaceutical vehicle.
A method of protecting an organ, comprising:
- identifying a subject in need of protection of an organ;
- and
- administering a pharmaceutical formulation to a subject in need thereof, the pharmaceutical formulation comprising a non-deuterated form of tetrahydrocurcumin or a deuterated form of tetrahydrocurcumin and a pharmaceutical vehicle.
A method of treating or preventing heart failure in a subject in need, comprising:
- identifying a subject in need of treatment for or prevention of heart failure;
- and
- administering pharmaceutical formulation to a subject in need thereof, the pharmaceutical formulation comprising a non-deuterated form of tetrahydrocurcumin or a deuterated form of tetrahydrocurcumin and a pharmaceutical vehicle.
A pharmaceutical formulation comprising a non-deuterated form of tetrahydrocurcumin or a deuterated form of tetrahydrocurcumin and a pharmaceutical vehicle.
Dependencies are inferred from the claim text.